Company Filing History:
Years Active: 2011
Title: Innovations by Chung Faye Chao
Introduction
Chung Faye Chao is a notable inventor based in Taipei, Taiwan. He has made significant contributions to the field of medical research, particularly in the area of receptor mRNA regulation. His work focuses on developing innovative solutions for diseases related to endothelin receptor A over-expression.
Latest Patents
Chao holds a patent for "Derivatives of 8-epiblechnic acid and their effects on down-regulation of endothelin (ETA) receptor mRNA." This patent discloses derivatives of 8-epiblechnic acid and their use in treating diseases associated with endothelin receptor A or endothelin-1 (ET-1) over-expression. These diseases include hypertension, cancer, atherosclerosis, and myocardial infarction. He has 1 patent to his name.
Career Highlights
Chao is currently employed at Scinopharm Taiwan, Ltd., where he continues to advance his research and development efforts. His work at the company has positioned him as a key player in the pharmaceutical industry, contributing to innovative treatments that address critical health issues.
Collaborations
Chao collaborates with esteemed colleagues, including Hardy W Chan and Vallapa Soong. These partnerships enhance the research and development process, fostering an environment of innovation and discovery.
Conclusion
Chung Faye Chao's contributions to medical research and his innovative patent demonstrate his commitment to addressing significant health challenges. His work continues to impact the field positively, paving the way for future advancements in treatment options.